Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Methods Mol Biol. 2018;1783:259–277. doi: 10.1007/978-1-4939-7834-2_13

Table 3.

Unique genes identified in human pulmonary hypertension.

Publication Gene(s) identified PH Classification
Thomson, J.R. et al. 2000 [45]
Newman, J.H. et al. 2001 [44]
BMPR2 PAH
Trembath, R.C. et al. 2001 [53] ALK1 PAH
Chaouat A. et al. 2004 [52] Eng PAH
Shintani, M. et al. 2009 [50] Smad9 PAH
Austin, E.D. et al. 2012 [54] CAV1 PAH
Ma, L. et al. 2013 [55] KCNK3 PAH
Risbano et al. 2010 [58] 1L7R, LRRN3, NOG, NMT2, TUBE1, MAP9, CCR7, TGFBR2 SSc-PAH
Gaskill et al. 2016 [61] SPON2, PEAR1, TNC, NEO1, DKK1, PDK4, WLS, RGS5, PTGS2 PAH (fibroblasts)
Garcia-Lucio, J. et al. 2016 [70] ANGPT-2 COPD-PH
Hoffman, J. et al. 2014 [72] Upregulated
FOSB, BTG2, NPTXR, MYOM1, ZNF776, RERGL, EGR1, LOC572558, NTRK3, S1K1
Downregulated
UBE2C, CMTM3, SNX24, CLDN4, NEDD4L, ZNF521, SLC34A3, SLC34A2, COL6A3, NCEH1, SERP1NA1,
HOPX, DHCR24, 1RX3, NKX2-1, SCNN1A, TJP3, POSTN, GGT5
COPD-PH
Hoffman, J. et al. 2014 [72] Upregulated
S100A2, MMP1, SCGB1A1, MMP7, C20orf85, BCAS1, CXCL14, KRT17, WDR38, TR1M29, S1X1, BDKRB2, GPX2, CL1C6, TUBB3, HMGB3, SCGB3A1, CLCA2, C6orf165, SOX2, CBX8, STK33, SAA2, MUC4, FANK1
Downregulated
TMEM88, PDE1B, MMRN2, PLA1A, C1orf115, PTPRR, IDO1, CLDN5, CLEC14A, PNMT, PCYT2, SDPR, HBA2, ADRB2
IPF-PH
Hoffman, J. et al 2014 [72] Upregulated
UGT1A6, ALDH1A1, CYP2A7, RDH10, LAMC2, SDC1, LAMB3, COL3A1, COL6A3, TNC, 1TGB6, THBS2
Downregulated
CYP4A11, CYP2C19, ADH5, PNPLA4, ALDH1A2, CYP26B1, VWF, ITGA8
IPF-PH vs COPD-PH
Gu, S. et al. 2014 [74] ORL1, IL8 CTEPH
Desai, A.A. et al. 2012 [79] ADORA2B, C1QBP, ADC, MYL10, PRELP, SPDEF, GALNT13, SLC27A5, NAT8L, C9orf16 SCD-PH
Singla, S. et al. 2016 [80] HIST1H4C, ETHE1, WASF1, RGS19, CORO1B, CACHD1, SUMO4, LOC100128751, RASSF3, STOX1, CD177, SERPINB8, FXYD6, NRCAM, RCVRN, BLOC1S1, SH3BGRL3, SLC22A16 Sarcoidosis-PH

PAH indicates pulmonary arterial hypertension, SSc-PAH, pulmonary arterial hypertension related to systemic sclerosis; COPD-PH, pulmonary hypertension related to chronic obstructive pulmonary disease; IPF-PH, pulmonary hypertension related to idiopathic pulmonary fibrosis; CTEPH, chronic thromboembolic pulmonary hypertension; SCD-PH, pulmonary hypertension related to sickle cell disease.